VR Logo

Unrated

Nippon India Pharma Fund


1 Lakh

Investment Grown to
₹ 2.02 Lakh

₹ 10000

Monthly SIP Grown to
₹ 5.90 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 20.89 1.15 1.39 1.71 0.90 4.10 30.05 26.42 16.44 13.76 19.36
S&P BSE Healthcare TRI 18.85 1.18 1.76 1.72 0.15 4.09 28.05 22.62 11.10 8.80 16.49
Equity: Sectoral-Pharma 16.87 1.43 1.61 1.00 0.00 4.37 25.81 26.43 13.25 11.24 17.59
Rank within category 2 11 10 6 2 8 2 3 1 1 1
Number of funds in category 10 15 15 14 13 12 10 6 4 3 3

As on 26-Nov-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Nippon India Pharma Fund
Unrated
Jun-04 30.05 26.42 16.44 1.89% 5,210
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 25.55 26.91 -- 1.99% 3,045
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 23.43 23.41 10.29 2.11% 1,872
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 33.23 31.21 -- 2.08% 1,798
DSP Healthcare Fund - Regular Plan  | Invest Online
Unrated
Nov-18 26.60 -- -- 2.16% 1,404

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 21.37 01-Apr-2020 - 09-Apr-2020 -19.70 15-Jan-2008 - 22-Jan-2008
Month 38.52 23-Mar-2020 - 22-Apr-2020 -32.30 12-May-2006 - 13-Jun-2006
Quarter 60.76 05-Mar-2009 - 04-Jun-2009 -29.88 03-Jan-2008 - 03-Apr-2008
Year 175.79 25-Mar-2009 - 25-Mar-2010 -36.67 26-Oct-2007 - 27-Oct-2008

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund 23.75 20.07 0.99 2.24 0.90 4.78
S&P BSE Healthcare TRI 20.65 21.78 0.77 1.72 -- --
Equity: Sectoral-Pharma 24.08 19.88 1.02 2.31 0.89 5.21
Rank within category 3 4 4 5 3 4
Number of funds in category 6 6 6 6 6 6

The Risk Measures have been calculated using calendar month returns for the last three years.

As on 31-Oct-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 22
Top 10 Stocks (%) 70.43
Top 5 Stocks (%) 44.00
Top 3 Sectors (%) 95.36
Portfolio P/B Ratio 4.66
Portfolio P/E Ratio 27.76

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 46,311 56,104
Giant (%) 12.16 15.64
Large (%) 45.48 41.83
Mid (%) 32.55 35.12
Small (%) 9.80 7.40
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
equal Sun Pharmaceutical Industries Healthcare 29.53 12.32 7.94 11.60
equal Dr. Reddy's Lab Healthcare 40.25 11.04 6.32 9.39
down Divi's Laboratories Healthcare 61.32 11.18 7.74 7.91
up Cipla Healthcare 30.12 11.10 5.81 7.82
equal Aurobindo Pharma Healthcare 7.62 11.96 5.49 7.28
up Apollo Hospitals Healthcare 78.32 6.76 0.00 6.55
equal Lupin Healthcare -- 10.30 4.76 5.49
equal Abbott India Healthcare 57.04 7.97 2.23 4.95
equal Narayana Hrudayalaya Healthcare 39.15 4.93 1.04 4.93
up Torrent Pharmaceuticals Healthcare 40.07 4.51 0.00 4.51
down Gland Pharma Healthcare 52.14 6.63 0.00 4.29
equal Thyrocare Technologies Healthcare 28.58 6.84 3.63 4.12
equal Sanofi India Healthcare 19.10 6.70 1.86 3.35
down Fortis Healthcare Healthcare 48.38 7.28 3.28 3.28
equal Cadila Healthcare Healthcare 10.10 6.53 2.39 2.90
down Indoco Remedies Healthcare 28.72 2.50 0.67 2.09
up Vijaya Diagnostic Centre Healthcare 70.25 1.30 0.00 1.30
up Pfizer Healthcare 41.73 1.21 0.00 1.21
equal Orchid Pharma Healthcare -- 1.68 0.00 0.76
equal Jubilant Pharmova Healthcare 11.48 2.51 0.00 0.63
equal Alkem Laboratories Healthcare 25.27 6.36 0.04 0.55
equal Healthcare Global Enterprises Healthcare -- 0.82 0.26 0.45

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Oct-2021

Fund Manager

— Sailesh Raj Bhan since 01-Mar-2005

Education: Mr. Bhan is an MBA (Finance) and CFA.

Experience: Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.

Funds Managed:


1.15%

Change from previous, NAV as on 26-Nov-2021

Growth: ₹ 305.9485

IDCW: ₹ 88.7894

Bonus: ₹ 305.9485


Investment Strategy

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 1,000
Minimum SIP Investment (₹) 100
Minimum No of Cheques 60
Minimum Withdrawal (₹) 100
Minimum Balance (₹) 1
Lock-in Period Not Applicable
Exit Load 1% for redemption within 30 days

Basic Details

Fund House: Nippon India Mutual Fund
Launch Date: 05-Jun-2004
Return Since Launch: 21.61%
Benchmark: S&P BSE Healthcare TRI
Riskometer: Very High
Type: Open-ended
Assets: ₹ 5,210 Cr (As on 31-Oct-2021)
Expense: 1.89% (As on 31-Oct-2021)
Risk Grade: --
Return Grade: --
Turnover: 49.00%

Most Recent Dividends

Plan Record Date Dividend (₹ / Unit)  
IDCW26-Feb-20216.0000

 28-Feb-20203.9843
 01-Mar-20194.4270
 01-Mar-20186.0000
 03-Mar-20176.5000
 04-Mar-20167.0000
 30-Jan-20157.0000
 14-Feb-20144.5000
 11-Jan-20133.5000
 16-Mar-20121.0000
 25-Feb-20112.5000
 28-Aug-20091.5000
 19-Mar-20081.5000
 21-Feb-20071.5000
 19-Dec-20051.0000

Contact Information

AMC: Nippon Life India Asset Management Ltd.

Address: 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai - 400013

Phone: 022-68334800 / 18602660111

Fax: 022-33037662

Email: [email protected]

Website: http://www.nipponindiamf.com

Registrar & Transfer Agent: KFin Technologies Pvt Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Investors' Hangout

Stocks or Equity Funds for the long term?

DateFriday, 10-Dec-2021
Time12:30 PM - 01:00 PM

attending You have reserved a spot